SCHEMBL23300916

SCHEMBL23300916

COC(=O)CCC(=O)c1cc(-c2csc3ccccc23)cs1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.43
HDAC2 Q92769 1/20 0.40
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 2/20 0.37
APP P05067 1/20 0.37
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
PTGER2 P43116 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP2A6 P11509 1/20 0.36
RAB9A P51151 1/20 0.36
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23330718 0.90 ERN1 (0.45) ERN1HDAC2PKMLMNATP53
SCHEMBL23330457 0.87 POLQ (0.37) KDM4EPKMLMNAALDH1A1POLB
SCHEMBL29832289 0.87 POLQ (0.37) KDM4EPKMLMNAALDH1A1POLB
SCHEMBL24721661 0.86 ERN1 (0.44) ERN1HDAC2PKMAPPALDH1A1
SCHEMBL23330450 0.85 CYP1A2 (0.45) ERN1HDAC2LMNAAPPALDH1A1
SCHEMBL29831249 0.83 CYP2C19 (0.47) KDM4ELMNAALDH1A1POLBCYP1A2
SCHEMBL23330455 0.83 CYP2C19 (0.47) KDM4ELMNAALDH1A1POLBCYP1A2
SCHEMBL23330327 0.83 KDM4E (0.36) KDM4ELMNAALDH1A1POLBCYP1A2
SCHEMBL29831732 0.83 PARP14 (0.44) KDM4ELMNAALDH1A1POLBCYP1A2
SCHEMBL23300732 0.81 STING1 (0.39) ERN1KDM4EPKMLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112724127-B Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2023-02-17 CN disclosed
US-20230032101-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2023-02-02 US disclosed
EP-4053124-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2022-09-07 EP disclosed
CN-114829357-A Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2022-07-29 CN disclosed
WO-2021083060-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF 中国科学院上海药物研究所 2021-05-06 WO disclosed
WO-2021083060-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF 中国科学院上海药物研究所 2021-05-06 WO disclosed
CN-112724127-A Five-membered heterocyclic oxocarboxylic acid compound and medical application thereof 中国科学院上海药物研究所 2021-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230032101-A1 FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF STING1, CGAS, IRF3 ERN1 2328/4885HDAC2 3273/4885KDM4E 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.